Abstract:BACKGROUND: Doxorubicin (DOX) is a highly effective broad-spectrum antitumor agent, but its clinical administration is limited by self-induced cardiotoxicity. Dihydromyricetin (DHM) is a flavonoid compound extracted from the Japanese raisin tree. Evidence that DHM has neovascular protective properties makes it a candidate for studying cardiotoxicity prevention strategy. However, it remains unknown if DHM can protect against cardiotoxicity caused by DOX.PURPOSE: The present study was performed to evaluate the protective effect of DHM on DOX-induced cardiotoxicity in vivo and in vitro.METHODS: C57BL/6 mice were intraperitoneally injected with DOX to construct cardiac injury model in vivo, and AC16 cells were exposed to DOX to induce cell injury in vitro. Left ventricular function of mice were detected by echocardiography, the apoptosis of mice cardiac tissue and AC16 cells were detected by TUNEL and Hoechst33342/PI double staining. The expression of apoptosis and autophagy related proteins were detected by western blotting, immunohistochemical staining and immunofluorescence staining.RESULTS: Echocardiographic results showed that DOX-induced cardiotoxicity were significantly alleviated by DHM pretreatment. DOX induced cardiotoxicity of mice by inhibiting AMPK activation, increasing apoptosis and decreasing autophagy. However, under the same conditions, the heart tissue of DHM-pretreated mice showed increased autophagy and decreased apoptosis via activation AMPK/mTOR pathway. The same results were observed in vitro, and it was also found that DHM can inhibit the production of intracellular ROS in vitro.CONCLUSION: DHM protects against cardiotoxicity by inhibiting apoptosis and oxidative stress and it can allevate theautophagy inhibition caused by DOX through AMPK/mTOR pathway. DHM preconditioning may be a breakthrough in protecting DOX-induced cardiotoxicity in the future clinical applications.

3,3′-Diindolymethane Ameliorates Adriamycin-Induced Cardiac Fibrosis Via Activation of a BRCA1-dependent Anti-Oxidant Pathway

DIM Attenuates TGF-β1-induced Myofibroblast Differentiation in Neonatal Rat Cardiac Fibroblasts.

3,3′-Diindolylmethane Protects Against Cardiac Hypertrophy Via 5′-Adenosine Monophosphate-Activated Protein Kinase-α2

Attenuation of doxorubicin-induced cardiotoxicity and genotoxicity by an indole-based natural compound 3,3′-diindolylmethane (DIM) through activation of Nrf2/ARE signaling pathways and inhibiting apoptosis

Dihydromyricetin Prevents Cardiotoxicity and Enhances Anticancer Activity Induced by Adriamycin.

3,3'-Diindolylmethane Attenuates Cardiac H9c2 Cell Hypertrophy Through 5'-Adenosine Monophosphate-Activated Protein Kinase-Α.

Protective effect of diindolylmethane‐enriched dietary cabbage against doxorubicin‐induced cardiotoxicity in mice

Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1

Preventive effect of imperatorin against doxorubicin-induced cardiotoxicity through suppression of NLRP3 inflammasome activation

AKT inhibitor AZD5363 suppresses stemness and promotes anti-cancer activity of 3,3′-diindolylmethane in human breast cancer cells

Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress

Protective Effect of Beta-CasomorPhin-7 on Oxidative Stress and Inflammatory Response in Adriamycin Cardiomyopathy

Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway

3,3′-Diindolylmethane attenuates inflammation and fibrosis in radiation-induced lung injury by regulating NF-κB/TGF-β/Smad signaling pathways

3,3 '-Diindolylmethane Decreases Vcam-1 Expression and Alleviates Experimental Colitis Via A Brca1-Dependent Antioxidant Pathway

3,3′‐Diindolylmethane Ameliorates Experimental Hepatic Fibrosis Via Inhibiting Mir‐21 Expression

Protective effects of dimethyl itaconate in mice acute cardiotoxicity induced by doxorubicin

Adriamycin induces cardiac fibrosis in mice via PRMT5-mediated cardiac fibroblast activation

A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity

Fasudil protects against adriamycin-induced acute heart injury by inhibiting oxidative stress, apoptosis and cellular senescence.

Pilose Antler Peptide-3.2KD Ameliorates Adriamycin-Induced Myocardial Injury Through TGF-β/SMAD Signaling Pathway